Malaria is a vector-borne disease that affected up to 241 million people just last year,
causing more than 602 thousand deaths in Africa alone. Global strategies for malaria control …

Although the last two decades have seen a substantial decline in malaria incidence and
mortality due to the use of insecticide-treated bed nets and artemisinin combination therapy …

Malaria remains one of the deadliest diseases in Africa, particularly for children. While
successful in reducing morbidity and mortality, antimalarial treatments are also a major …

Resistance to antimalarial drugs, and in particular to the artemisinin derivatives and their
partner drugs, threatens recent progress toward regional malaria elimination and eventual …

Malaria remains a significant public health concern in Africa, with millions of cases reported
annually. However, the effectiveness of antimalarial drugs, a cornerstone of malaria control …

The potential spread of antimalarial drug resistance to Africa, in particular for artemisinins
and key partner drugs, is a major concern. We surveyed Plasmodium falciparum genetic …

Drug resistance in malaria jeopardizes the most elementary objectives of malaria control–
reducing suffering and eliminating mortality. An important, and so far the only known …

The biggest threat to the war on malaria is the continued evolution of drug resistance by the
parasite. Resistance to almost all currently available antimalarials now exists in Plasmodium …

Malaria caused by the Plasmodium parasites is a major public health concern in malaria-
endemic regions with P. falciparum causing the most severe form of the disease. The use of …

Drug resistance has emerged as one of the greatest challenges facing malaria control. The
recent emergence of resistance to artemisinin (ART) and its partner drugs in ART-based …